{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Pipendoxifene",
  "nciThesaurus": {
    "casRegistry": "198480-55-6",
    "chebiId": "",
    "chemicalFormula": "C29H32N2O3",
    "definition": "A nonsteroidal 2-phenyl indole and a selective estrogen receptor modulator (SERM) with potential antineoplastic activity. Pipendoxifene antagonizes binding of estradiol to estrogen receptor alpha (ER alpha), thereby inhibiting ER alpha-mediated gene expression, interfering with estrogen activity and inhibiting estrogen-stimulated growth in estrogen-dependent breast cancer. In addition, this agent also exerts intrinsic estrogenic activity depending on the tissue types.",
    "fdaUniiCode": "TPC5Q8496G",
    "identifier": "C1874",
    "preferredName": "Pipendoxifene",
    "semanticType": "Organic Chemical",
    "subclassOf": [
      "C1821"
    ],
    "synonyms": [
      "2-(4-Hydroxyphenyl)-3-methyl-1-[4-(2-piperidin-1-ylethoxy)benzyl]-1H-indol-5-ol Hydrochloride",
      "ERA 923",
      "ERA-923",
      "PIPENDOXIFENE",
      "Pipendoxifene"
    ]
  }
}